Compare Amphastar Pharmaceuticals Inc (AMPH) vs Mattel Inc (MAT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amphastar Pharmaceuticals Inc vs Mattel Inc — how do they compare? Amphastar Pharmaceuticals Inc trades at $19.38 (market cap $826.08M), while Mattel Inc trades at $13.86 (market cap $3.87B). The key difference: Mattel Inc is far larger — about 4.7× Amphastar Pharmaceuticals Inc's market cap. Which is the better fit depends on your goals.
| AMPH | MAT | |
|---|---|---|
Market Cap | $826.08M | $3.87B |
Sector | Health | Consumer Cyclical |
52-Week High | $30.81 | $22.16 |
52-Week Low | $16.87 | $13.05 |
Enterprise Value | $1.22B | $5.68B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Amphastar Pharmaceuticals Inc
Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.
Read more on AMPH →About Mattel Inc
Mattel markets toy products that are sold to its wholesale customers and direct to retail consumers. The company offers products for children and families, including toys for infants and preschoolers, girls and boys, youth electronics, handheld and other games, puzzles, educational toys, media-driven products, and plush and fashion-related toys. Mattel's owned portfolio includes Barbie, Hot Wheels, Fisher-Price, Thomas & Friends, and American Girl. In addition, it currently manufactures toy products for its segments both internally and externally (through manufacturing partners). Just over half of its net sales are in North America, while the remainder stem from international markets.
Read more on MAT →
